The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 7485416 B1

PDF
Full Text
Expired
Date of Patent:
Feb. 03, 2009

Filed:

Dec. 22, 2004
Applicants:

Melanie Ott, San Francisco, CA (US);

Eric M. Verdin, San Francisco, CA (US);

Manfred Jung, Freiburg, DE;

Inventors:

Melanie Ott, San Francisco, CA (US);

Eric M. Verdin, San Francisco, CA (US);

Manfred Jung, Freiburg, DE;

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/70 (2006.01); A61K 39/21 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention provides treatment methods involving modulating a sirtuin activity and/or a sirtuin mRNA and/or a sirtuin polypeptide level. In some embodiments, the present invention provides treatment methods involving modulating SIRT1 activity and/or SIRT mRNA and/or polypeptide level. The present invention provides methods of inhibiting SIRT1 Tat deacetylase activity. Methods of inhibiting SIRT1 Tat deacetylase activity are useful for treating immunodeficiency virus infections, particularly human immunodeficiency virus (HIV) infection. Thus, the present invention provides methods of treating an immunodeficiency virus infection, generally involving inhibiting SIRT1 Tat deacetylase activity. The present invention further provides methods of identifying agents that modulate sirtuin activity (e.g., SIRT1 activity), particularly ability of sirtuins to interact with (e.g., bind and/or deacetylate) a substrate, e.g., a viral substrate such as a Tat polypeptide. The present invention further provides active agents that modulate sirtuin activity or expression; and compositions, including pharmaceutical compositions, comprising the active agents.


Find Patent Forward Citations

Quick Actions:

Ott, Melanie. (2009). Screening methods for the identification of agents that inhibit sirt1 tat deacetylase activity (U.S. Patent No. 7485416). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/7485416

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…